CRH plc (CRH) Tops Q3 EPS by 6c, cuts forecast
Get Alerts CRH Hot Sheet
Join SI Premium – FREE
CRH plc (NYSE: CRH) reported Q3 EPS of $2.09, $0.06 better than the analyst estimate of $2.03. Revenue for the quarter came in at $11.4 billion versus the consensus estimate of $11.56 billion.
GUIDANCE:
CRH plc sees Q4 2026 EPS of $4.63-$4.85, versus the consensus of $5.57.
For earnings history and earnings-related data on CRH plc (CRH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- Astera Labs, Inc. (ALAB) Tops Q3 EPS by 13c, Beats on Revenue
- Tarsus Pharmaceuticals, Inc. (TARS) Misses Q3 EPS by 1293c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share